Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice.

Animals Atherosclerosis / metabolism Female Injections, Subcutaneous Lipoproteins, HDL / metabolism Lipoproteins, LDL / metabolism Mice Mice, Inbred C57BL Mice, Knockout Peptides / administration & dosage Receptors, LDL / deficiency
HDL LDL apolipoprotein J atherosclerosis lipoprotein function mice mimetic peptide

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
29 05 2020
Historique:
received: 02 04 2020
revised: 19 05 2020
accepted: 21 05 2020
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 10 4 2021
Statut: epublish

Résumé

Mimetic peptides are potential therapeutic agents for atherosclerosis. d-[

Identifiants

DOI: 10.3390/biom10060829 PMID: 32485898 PMC: PMC7356811
pubmed: 32485898
pii: biom10060829
doi: 10.3390/biom10060829
pmc: PMC7356811
pii:
doi:

Substances chimiques

Lipoproteins, HDL 0
Lipoproteins, LDL 0
Peptides 0
Receptors, LDL 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI13/00364
Pays : International
Organisme : Instituto de Salud Carlos III
ID : FI17/00031
Pays : International
Organisme : Instituto de Salud Carlos III
ID : PI16/00471
Pays : International
Organisme : Instituto de Salud Carlos III
ID : PI17-00232
Pays : International
Organisme : Instituto de Salud Carlos III
ID : PI16-00139
Pays : International
Organisme : Instituto de Salud Carlos III
ID : CB07/06/2008
Pays : International
Organisme : Instituto de Salud Carlos III
ID : CB07/08/0016
Pays : International

Références

Artery Res. 2017 Dec;20:8-11
pubmed: 29430260
Eur Heart J. 2018 Jul 14;39(27):2562-2573
pubmed: 29982602
Front Cardiovasc Med. 2019 Apr 12;6:46
pubmed: 31032262
Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2169-75
pubmed: 19762782
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2886-2903
pubmed: 30522652
Nat Rev Cardiol. 2016 Jan;13(1):48-60
pubmed: 26323267
Curr Med Chem. 2019;26(9):1665-1679
pubmed: 29600751
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Curr Cardiol Rep. 2018 Jun 21;20(8):66
pubmed: 29926215
J Lipid Res. 2010 Jun;51(6):1496-503
pubmed: 20075422
Handb Exp Pharmacol. 2015;224:631-48
pubmed: 25523005
Circulation. 2017 Jun 20;135(25):2494-2504
pubmed: 28450350
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1932-7
pubmed: 15961700
Curr Top Med Chem. 2016;16(18):2009-18
pubmed: 26876522
FASEB J. 2015 May;29(5):1688-700
pubmed: 25550461
J Med Chem. 2014 Mar 27;57(6):2169-96
pubmed: 24168751
J Nutr Biochem. 2016 Apr;30:44-52
pubmed: 27012620
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):246-52
pubmed: 19965776
Biochim Biophys Acta. 2011 Jan;1808(1):498-507
pubmed: 20970404
Am J Transl Res. 2016 Aug 15;8(8):3482-92
pubmed: 27648138
J Am Coll Cardiol. 2019 Mar 5;73(8):948-963
pubmed: 30819364
Sci Transl Med. 2020 Jan 29;12(528):
pubmed: 31996466
Cardiovasc Diabetol. 2014 Jan 24;13:26
pubmed: 24460800
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Atherosclerosis. 2018 Sep;276:39-43
pubmed: 30029099
Curr Opin Lipidol. 1995 Aug;6(4):196-208
pubmed: 7670748
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158541
pubmed: 31672573
Circ J. 2015;79(12):2523-8
pubmed: 26548857
Circulation. 2007 Oct 16;116(16):1832-44
pubmed: 17938300
J Clin Invest. 1955 Sep;34(9):1345-53
pubmed: 13252080
Front Pharmacol. 2017 Jan 06;7:526
pubmed: 28111551
Atherosclerosis. 2002 Jan;160(1):223-32
pubmed: 11755941
J Nat Prod. 2015 Feb 27;78(2):225-33
pubmed: 25692815
Circ Res. 2004 Oct 15;95(8):789-97
pubmed: 15388641
Mediators Inflamm. 2013;2013:181324
pubmed: 24062611
Lipids. 2011 Sep;46(9):805-11
pubmed: 21638064
Expert Rev Cardiovasc Ther. 2020 Mar;18(3):127-130
pubmed: 32200670
J Lipid Res. 2014 Oct;55(10):2007-21
pubmed: 25157031
Trends Cardiovasc Med. 2001 Apr-May;11(3-4):93-102
pubmed: 11686009
Int J Mol Sci. 2018 Nov 06;19(11):
pubmed: 30404132
J Lipid Res. 2015 Jun;56(6):1206-21
pubmed: 25861792
Nat Rev Cardiol. 2019 Jul;16(7):389-406
pubmed: 30846875
Curr Opin Lipidol. 2014 Jun;25(3):221-6
pubmed: 24811298
Diabetes. 2007 Dec;56(12):2863-71
pubmed: 17728375
Int J Biomed Sci. 2009 Dec;5(4):402-10
pubmed: 23675165

Auteurs

Andrea Rivas-Urbina (A)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Biochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona, 08193 Cerdanyola, Spain.
ORCID: 0000-0002-0111-0477

Anna Rull (A)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili, 43005 Tarragona, Spain.

Joile Aldana-Ramos (J)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.

David Santos (D)

Molecular Basis of Cardiovascular Risk, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.

Nuria Puig (N)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.

Nuria Farre-Cabrerizo (N)

Molecular Basis of Cardiovascular Risk, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.

Sonia Benitez (S)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.

Antonio Perez (A)

CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.
Endocrinology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
ORCID: 0000-0001-5528-1143

David de Gonzalo-Calvo (D)

Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, 25198 Lleida, Spain.
CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.
ORCID: 0000-0003-2240-3532

Joan Carles Escola-Gil (JC)

Molecular Basis of Cardiovascular Risk, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.
ORCID: 0000-0001-9021-2485

Josep Julve (J)

Molecular Basis of Cardiovascular Risk, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.
ORCID: 0000-0002-6531-2246

Jordi Ordoñez-Llanos (J)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Biochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona, 08193 Cerdanyola, Spain.

Jose Luis Sanchez-Quesada (JL)

Cardiovascular Biochemistry Group, Research Institute of the Hospital de Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, 28029 Madrid, Spain.
ORCID: 0000-0003-0224-591X

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Artériopathies oblitérantes › Artériosclérose › Athérosclérose › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Injections › Injections sous-cutanées › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Lipoprotéines › Lipoprotéines HDL › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Lipoprotéines › Lipoprotéines LDL › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Subcutaneous Administration of Apolipoprotein...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux lipoprotéines › Récepteurs aux lipoprotéines LDL › Subcutaneous Administration of Apolipoprotein...